BE825755A - Nouvelles 1-(3-(naphtyl-1-oxy)-2-hydroxy-propyl)-piperazines et procedes pour leur preparation - Google Patents

Nouvelles 1-(3-(naphtyl-1-oxy)-2-hydroxy-propyl)-piperazines et procedes pour leur preparation

Info

Publication number
BE825755A
BE825755A BE153540A BE153540A BE825755A BE 825755 A BE825755 A BE 825755A BE 153540 A BE153540 A BE 153540A BE 153540 A BE153540 A BE 153540A BE 825755 A BE825755 A BE 825755A
Authority
BE
Belgium
Prior art keywords
naphtyl
piperazines
news
oxy
propyl
Prior art date
Application number
BE153540A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE825755A publication Critical patent/BE825755A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE153540A 1974-02-23 1975-02-20 Nouvelles 1-(3-(naphtyl-1-oxy)-2-hydroxy-propyl)-piperazines et procedes pour leur preparation BE825755A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2408804A DE2408804C2 (de) 1974-02-23 1974-02-23 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten

Publications (1)

Publication Number Publication Date
BE825755A true BE825755A (fr) 1975-08-20

Family

ID=5908286

Family Applications (1)

Application Number Title Priority Date Filing Date
BE153540A BE825755A (fr) 1974-02-23 1975-02-20 Nouvelles 1-(3-(naphtyl-1-oxy)-2-hydroxy-propyl)-piperazines et procedes pour leur preparation

Country Status (20)

Country Link
US (1) US3997666A (da)
JP (1) JPS6029712B2 (da)
AR (1) AR206339A1 (da)
AT (1) AT340937B (da)
BE (1) BE825755A (da)
CA (1) CA1039282A (da)
CH (2) CH612958A5 (da)
DE (1) DE2408804C2 (da)
DK (1) DK135124C (da)
ES (1) ES434829A1 (da)
FI (1) FI59248C (da)
FR (1) FR2261770B1 (da)
GB (1) GB1445548A (da)
IE (1) IE40678B1 (da)
NL (2) NL175059B (da)
PL (1) PL92131B1 (da)
SE (1) SE405601B (da)
SU (2) SU549085A3 (da)
YU (2) YU37156B (da)
ZA (1) ZA751031B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387971A1 (fr) * 1977-04-19 1978-11-17 Delalande Sa Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
EP0269383A3 (en) * 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
US4882330A (en) * 1986-11-21 1989-11-21 A. H. Robins Company, Incorporated 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3918543A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6358515B2 (en) 1997-01-30 2002-03-19 Senju Pharmaceutical Co., Ltd. Hydroquinone derivatives
KR100639543B1 (ko) 1998-09-30 2006-10-31 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
AU2003303041B2 (en) 2002-12-13 2008-07-24 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
MXPA05012900A (es) 2003-05-30 2006-02-22 Ranbaxy Lab Ltd Derivados de pirrol sustituidos.
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US7618972B2 (en) 2005-03-21 2009-11-17 Pfizer Inc Substituted triazole derivatives as oxytocin antagonists
EP1917257A1 (en) * 2005-08-10 2008-05-07 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
JP2009514851A (ja) 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
EP2077262A4 (en) 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVES AND THEIR USE
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN101671317B (zh) * 2009-10-09 2011-04-27 蚌埠丰原涂山制药有限公司 一种萘哌地尔的制备方法
CN101747293B (zh) * 2009-12-29 2011-12-07 蚌埠丰原涂山制药有限公司 萘哌地尔的制备方法
JP5807423B2 (ja) * 2011-07-21 2015-11-10 大日本印刷株式会社 ナフトピジルの製造方法
CN102816136A (zh) * 2012-09-18 2012-12-12 通化吉通药业有限公司 萘哌地尔制备方法
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
US9272980B2 (en) 2014-06-06 2016-03-01 Ktn Biotec, Inc. Anticancer agent
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
SU549085A3 (ru) 1977-02-28
AT340937B (de) 1978-01-10
JPS6029712B2 (ja) 1985-07-12
AU7826875A (en) 1976-08-19
DE2408804A1 (de) 1975-09-04
PL92131B1 (da) 1977-03-31
DE2408804C2 (de) 1983-09-22
FI59248B (fi) 1981-03-31
ZA751031B (en) 1976-02-25
NL7501877A (nl) 1975-08-26
NL175059C (nl)
NL175059B (nl) 1984-04-16
SE7501911L (da) 1975-08-25
CH612958A5 (da) 1979-08-31
FR2261770A1 (da) 1975-09-19
DK135124B (da) 1977-03-07
DK58175A (da) 1975-10-20
AR206339A1 (es) 1976-07-15
SU561514A3 (ru) 1977-06-05
FI750449A (da) 1975-08-24
CH609342A5 (da) 1979-02-28
YU104481A (en) 1983-04-27
IE40678B1 (en) 1979-08-01
ES434829A1 (es) 1976-12-01
CA1039282A (en) 1978-09-26
US3997666A (en) 1976-12-14
DK135124C (da) 1977-08-15
YU37157B (en) 1984-08-31
JPS50121286A (da) 1975-09-23
YU37156B (en) 1984-08-31
IE40678L (en) 1975-08-23
GB1445548A (en) 1976-08-11
FI59248C (fi) 1981-07-10
FR2261770B1 (da) 1978-08-04
ATA132375A (de) 1977-05-15
SE405601B (sv) 1978-12-18
YU38275A (en) 1983-04-27

Similar Documents

Publication Publication Date Title
BE825755A (fr) Nouvelles 1-(3-(naphtyl-1-oxy)-2-hydroxy-propyl)-piperazines et procedes pour leur preparation
MC1137A1 (fr) Hentriacontapeptides et procedes pour leur preparation
BE762629A (fr) Nouvelles phenoxy-hydroxypropylamines et methode pour leur preparation
FR2349603A1 (fr) Acrylamide-amidons et procede pour leur preparation
BE862578A (fr) Electrocatalyseurs et procede pour leur preparation
FR2408593B1 (fr) Nouvelles triazines et procede pour leur preparation
FR2282878A1 (fr) Nouvelles rifamycines et procede de leur preparation
BE837878A (fr) 4-arylpiperidines et procedes pour les preparer
BE788065A (fr) Nouvelles aza-benzimidazoles et procede pour leur preparation
FR2342662A1 (fr) Composition pesticides stabilisees et procedes pour leur utilisation
FR2279393A1 (fr) Nouvelles aryl-5 furamidines-2 et procede de leur preparation
BE832885A (fr) Derives de tetranydropyridine et de piperidine et procede pour leur preparation
BE857708A (fr) (((diphenylmethyl)-4 piperidino)methyl)-4 benzenamines et procedes de leur preparation
FR2288521A1 (fr) Nouvelles penicillines et procede pour leur preparation
FR2349576A1 (fr) Indazolyl-(4)-oxy-propanolamines et procedes pour leur preparation
BE809820A (fr) Nouvelles amines et procedes pour leur preparation
BE862800A (fr) Nouvelles dithienylalkylamines et procede pour leur preparation
FR2276047A1 (fr) Nouvelles penicillines du type bis et leur procede de preparation
BE832983A (fr) Cycloalkyl-13, 14-deshydro-protaglandines et procede pour leur preparation
BE784962A (fr) Nonapeptides et procedes pour leur preparation
BE805138A (fr) Nouvelles phenyl-amidino-urees substituees et procedes pour leur preparation
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
BE825289A (fr) Nouveau 1-phenoxy-3-isopropylamino-2-propanol et procede pour sa preparation.
BE814620A (fr) Dihydroxy-phenethyl-amines n-substituees et procedes pour leur preparation
FR2081542A1 (fr) Nouvelles amines et procedes pour leur preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BOEHRINGER MANNHEIM G.M.B.H.

Effective date: 19950220